AT510562T

Anti-AILIM antibodies for the treatment of Crohn's disease

Abstract

This record has no abstract on file.

Term

Term ended

Expired 18 February 2022, 4.6 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

41 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
2001089158JapanA
2002019291JapanA
0201361JapanW

Members41

Family members, oldest first
DocumentOfficeKind
CA2441577A1CanadaA1
WO02076504A1World Intellectual Property Organization (WIPO)A1
JP2002356443AJapanA
NO20034312D0NorwayD0
KR20030085567ARepublic of KoreaA
NO20034312LNorwayL
AU2003262479A1AustraliaA1
EP1374902A1European Patent Office (EPO)A1
HU0303622A2HungaryA2
HUP0303622A2HungaryA2
MXPA03008760AMexicoA
BR0208446ABrazilA
IL158088A0IsraelA0
SK13302003A3SlovakiaA3
US2004131608A1United States of AmericaA1
ZA200307438BSouth AfricaB
CZ20032692A3CzechiaA3
CN1537017AChinaA
RU2003131330ARussian FederationA
EP1374902A4European Patent Office (EPO)A4
AU2002232222B2AustraliaB2
AU2002232222B8AustraliaB8
KR100602940B1Republic of KoreaB1
AU2003262479B2AustraliaB2
RU2281118C2Russian FederationC2
CN1291757CChinaC
NZ528554ANew ZealandA
HU0303622A3HungaryA3
HUP0303622A3HungaryA3
US7465444B2United States of AmericaB2
JP4210454B2JapanB2
US2009155273A1United States of AmericaA1
EP1374902B1European Patent Office (EPO)B1
AT510562TThis recordAustriaT
ATE510562T1AustriaT1
US8052972B2United States of AmericaB2
NO332316B1NorwayB1
SK288036B6SlovakiaB6
CA2441577CCanadaC
IL158088AIsraelA
HU229378B1HungaryB1